This study revealed that the ApoA concentration in the BAVM group is markedly reduced relative to that in the controls, which could be caused if the low concentration of ApoA in the patient is not enough to protect the health of its blood vessels, which would lead to pathological progression of BAVM. The gene discussed is APOA1; the disease is arteriovenous malformations of the brain.